Target intelligence / Profile preview

Zinc finger protein 41 (ZNF41)

Target
ZNF41
Molecular classification
Transcription factor, KRAB domain-containing protein, C2H2-type zinc finger protein (Kruppel family)
01

Overview

Zinc finger protein 41 (ZNF41) is a transcription factor characterized by multiple C2H2 zinc finger DNA binding motifs and classic KRAB domains (KRAB-A and KRAB-B) that act as transcriptional repressors[1][2]. ZNF41 participates in the regulation of gene expression, likely through recognition of specific DNA sequences using its zinc finger motifs, and its KRAB domains serve to recruit corepressors, contributing to the silencing of target genes. ZNF41 is part of a gene cluster on chromosome Xp11.23 and shows alternative splicing, although the full-length nature of all its transcript variants is not fully understood[1]. KRAB-type zinc finger proteins play essential roles in cellular differentiation, transcriptional regulation, and chromatin remodeling, but ZNF41 itself is mainly discussed in research as a transcription factor, with rare disease associations (e.g., X-linked mental retardation syndromes). Despite the zinc finger family's general involvement in disease processes like cancer and developmental syndromes[3][2], there are no drugs or specific clinical targeting approaches described for ZNF41 at present. Its functions and importance are inferred primarily from its molecular family and structural motifs rather than direct experimental evidence[1][2][3][4].

Other names
ZNF41MGC8941MRX89zinc finger protein 41
02

Mechanism of action

Not applicable. No mechanism of action for drugs is described for this protein, as it is not an established therapeutic target.

03

Biological functions

Transcriptional repression (via KRAB-A and KRAB-B domains)DNA binding and regulation of gene expression (multiple zinc finger motifs)RNA binding and possible roles in RNA splicing
04

Disease associations

Neurodevelopmental disorder/Intellectual disability (associated with X-linked mental retardation in literature via gene mutations, but not widely described as a drug target)Congenital limb abnormalities (specifically, mutations in related zinc finger family members can cause postaxial polydactyly, but direct disease roles for ZNF41 are not broadly described)Other (general risk for disease by dysfunction of transcriptional regulation, as seen in zinc finger protein family)

Beyond the preview

Go deeper on Zinc finger protein 41 (ZNF41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein 41 (ZNF41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call